Antiatherosclerotic Effect of Baculovirus-Mediated Endostatin in Rabbits

YOU Bei,LI Biao,SHEN Wei-feng,LU Lin,YIN Gui-zhi,ZHANG Yi-fan,Zhao Long,JIA Shi-hai,YU Jin-de
DOI: https://doi.org/10.3969/j.issn.1674-8115.2005.08.004
2005-01-01
Abstract:Objective To investigate antiatherosclerotic effect in vivo of endostatin mediated by secretory recombinant baculovirus. Methods Intima denudation and lipid-rich breeding were utilized to develop atherosclerotic rabbits. Two weeks after injury, the control group and treated group were given intramuscularly 1×10 9pfu vehicle rBac-GFP and secretory recombinant baculovirus rBac-hEndo (which carried the human endostatin gene), respectively. The hepatic and renal functions of the rabbits were monitored. Two weeks later, all the injured vessels were excised and examined. Results There was no hepatic and renal toxicity observed in the rBac-hEndo treatment. Two weeks after treatment, the thickness of intima and stenosis of the atherosclerotic vessels in the rBac-hEndo treated rabbits were reduced significantly and intimal capillary formation was less than that in the vehicle-treated ones. Conclusion Endostatinsecreted in vivo by the skeletal muscle transduced by secretory recombinant baculovirus could inhibit effectively the development of atherosclerotic plaque formation, and this method is highly safe.
What problem does this paper attempt to address?